Physician profile
Kendra D Hayslett
NPI 1255588950
$2,638.65
in general payments reported to CMS, 2019-2025
14 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what 93% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,223 · 2020: $140 · 2021: $76.01 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,200.00 | 2025 | Bovine Collagen |
| Intuitive Surgical, INC. | $1,104.34 | 2019 | |
| Abbvie INC. | $72.55 | 2019-2021 | |
| Eisai INC. | $57.66 | 2019-2020 | |
| Amgen INC. | $34.56 | 2019-2020 | |
| Novo Nordisk INC | $33.25 | 2019-2021 | |
| Roche Diagnostics Corporation | $33.24 | 2019-2020 | |
| Therapeuticsmd, INC. | $24.45 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $18.83 | 2019 | |
| Daiichi Sankyo INC. | $18.50 | 2021 | |
| Pfizer INC. | $16.17 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.17 | 2019 | |
| Allergan, INC. | $11.93 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Hayslett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.